GlassScriptPhysician profile
Anthony Ted Chuang
NPI 1891082327
$5,481.64
in general payments reported to CMS, 2019-2025
36 companies · $2,267 in 2025
The $2,267 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2020: $20.66 · 2021: $20.00 · 2022: $98.90 · 2023: $1,075 · 2024: $1,856 · 2025: $2,267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,030 · Education: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,029.81 |
| Education | $168.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $772.66 | 2023-2025 | Freestyle Libre 3 |
| Novo Nordisk INC | $662.83 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $487.03 | 2023-2025 | Tepezza, Evenity, Prolia |
| Dexcom, INC. | $353.47 | 2023-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Lilly USA, LLC | $319.57 | 2024-2025 | Mounjaro, Zepbound, Jardiance |
| Xeris Pharmaceuticals, INC. | $311.84 | 2023-2025 | Gvoke Hypopen |
| Corcept Therapeutics | $280.86 | 2023-2025 | Korlym |
| Tandem Diabetes Care, INC. | $260.50 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Mannkind Corporation | $255.26 | 2023-2025 | Afrezza |
| Medtronic, INC. | $205.84 | 2024-2025 | Minimed 780g, Intellis Adaptivestim |
| Bayer Healthcare Pharmaceuticals INC. | $186.55 | 2023-2025 | |
| Abbvie INC. | $148.15 | 2024-2025 | |
| Insulet Corporation | $145.42 | 2025 | Omnipod, Omnipod |
| Sanofi-Aventis U.S. LLC | $136.24 | 2024-2025 | |
| Astellas Pharma US INC | $117.69 | 2025 | Veozah |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Chuang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.